tiprankstipranks

James Talevich Insider Profile

4 Followers
James Talevich, Director at Biolase, holds 20.37K shares in Biolase (Ticker: BIOL).
tipranks
James Talevich

James Talevich
Biolase (BIOL)
Director

Not Ranked
James Talevich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3K
100.00%
A breakdown of James Talevich's holdings

Insider Roles

Biolase
(BIOL)
Director
Roles that James Talevich holds in companies

Most Profitable Insider Trade

Stock:
Biolase
(BIOL)
Rating:Informative Buy
Date:Dec 06, 2017 - Dec 06, 2018
Return:-44.30%
The most profitable trade made by James Talevich

James Talevich's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biolase
May 14, 2018
Director
Uninformative Buy
$3.42K
Success Rate for
BIOL
0 out of 1 profitable transactions on
BIOL
0%
Average Return for
BIOL
Average return per transaction on
BIOL
-44.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 31, 2015
Uninformative Buy
$0.00
-
$0.00
May 10, 2017
Uninformative Buy
$0.00
-
$0.00
Dec 06, 2017
Informative Buy
$1.44K
-
$0.45
-44.30%
May 14, 2018
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see James Talevich's performance on stock

James Talevich insider profile FAQ

What is the percentage of profitable transactions made by James Talevich?
The percentage of profitable transactions made by James Talevich is ―.
    What is the average return per transaction made by James Talevich?
    The average return per transaction made by James Talevich is ―.
      What stocks does James Talevich hold?
      James Talevich holds: BIOL stocks.
        What was James Talevich’s latest transaction?
        James Talevich latest transaction was an Uninformative Buy of ―.
          What was James Talevich's most profitable transaction?
          James Talevich’s most profitable transaction was an Informative Buy of BIOL stock on December 6, 2017. The return on the trade was -44.30%.
            What is James Talevich's role in Biolase?
            James Talevich's role in Biolase is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.